Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Biopharmaceutical properties of mucoadhesive powder platform for donepezil nasal delivery

  • At: Seville (Spain) (2022)
  • Type: Poster
  • Poster code: DDD-020
  • By: NIžIć NODILO, Laura (University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Physical Chemistry, Croatia)
  • Co-author(s): Ms Mirna Perkušić, Department of Pharmaceutical Technology (University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology, Zagreb, Croatia)
    Ms Laura Nižić Nodilo, Research Assistant (University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology, Zagreb, Croatia)
    Ms Cvijeta Jakobušić Brala, Department of Physical Chemistry (University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Physical Chemistry, Zagreb, Croatia)
    Mr Ivan Pepić, Department of Pharmaceutical Technology (University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology, Zagreb, Croatia)
    Ms Jasmina Lovrić, Department of Pharmaceutical Technology (University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology, Zagreb, Croatia)
    Ms Anita Hafner, Department of Pharmaceutical Technology (University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology, Zagreb, Croatia)
  • Abstract:

    Background
    Donepezil hydrochloride (DH) is commonly used for the treatment of symptoms of Alzheimer’s disease as an oral dosage form (1). Nasal DH administration provides the potential for direct and efficient DH delivery to the central nervous system, while reducing its systemic side effects (2).
    Purpose
    The aim of this study is to investigate..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses